Growth Factor
CJC-1295 (No DAC) + Ipamorelin
CJC-1295 and Ipamorelin combine two distinct approaches to growth-hormone-axis investigation.
Vial
$104.30$149.00 was, now $104.30 In stock

GHRH analogues, secretagogues, and growth-factor peptides for growth-hormone-axis research.
CJC-1295 and Ipamorelin combine two distinct approaches to growth-hormone-axis investigation.
Vial
CJC-1295 with DAC is a long-acting analogue of growth-hormone-releasing hormone incorporating a drug-affinity-complex modification.
Vial
CJC-1295 without DAC (Mod GRF 1-29) is a short-acting analogue of growth-hormone-releasing hormone used in growth-hormone-axis research.
Vial
IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 engineered with structural changes that alter its interaction with IGF-binding proteins and extend its activity in experimental systems.
Vial
Ipamorelin is a synthetic pentapeptide recognized for its activity as a selective growth-hormone secretagogue.
Vial
Sermorelin is a synthetic peptide corresponding to the biologically active portion of growth hormone-releasing hormone.
Vial
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone designed to engage the GHRH receptor and stimulate the signaling cascade associated with pulsatile growth-hormone release.
Vial
Tesamorelin and Ipamorelin combine two distinct approaches to growth-hormone-axis investigation in a single formulation.
Vial







